홈BCRX • NASDAQ
add
바이오크리스트
전일 종가
$7.40
일일 변동폭
$7.08 - $7.40
52주 변동폭
$4.03 - $9.50
시가총액
15.09억 USD
평균 거래량
332.66만
주가수익률
-
배당수익률
-
기본 거래소
NASDAQ
뉴스
정보
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China. Wikipedia
CEO
설립
1986
웹사이트
직원 수
580
